See 2% margin growth in FY14: Nectar Lifesciences
May 16, 2013 at 13:54
0
Search Videos
The Indian markets have a lot of things going for it from the macro perspective but valuations may not be cheap once a stock investor gets done to researching ideas, says Sanjeev Prasad, Senior Executive Director and Co-Head Strategy, Kotak Instituti...
Source : CNBC-TV18

Share this video with Friends

Members: 4,826,690
   30 comments

Biocon...

thanks Sir...>

Posted by: invester1983      At: 30 May 2016 09:43      Category: Biocon
   27 comments

REC...

That`s a cool buy!!!!!...>

Posted by: KAYSB      At: 29 May 2016 07:24      Category: REC
Advances & Declines
S&P BSE Auto18851.24137.38
S&P BSE BANKEX20028.1577.05
Bank Nifty17567.3055.50
S&P BSE Capital Goods14521.531.64
S&P BSE Consumer Durables11694.7862.80
S&P BSE FMCG8139.218.04
S&P BSE Healthcare15446.1917.79
S&P BSE IT11733.93165.50
S&P BSE Metals7878.11194.51
S&P Oil & Gas9386.6936.48
S&P BSE PSU6232.4525.93
S&P BSE TECk6308.2076.39
S&P BSE Small Cap11147.3736.41
S&P BSE Mid-Cap11371.2824.25
CNX Midcap13298.9028.90